Aktuelle smitsomme sygdomme
Søgeord (covid-19) valgt.
25 emner vises.
1
PRO/AH/EDR> Avian influenza, human - USA (02): (CA) H5N1
ProMED
Tilføjet 14.01.2025
2
PRO/EDR> Human metapneumovirus - Bangladesh: (DH)
ProMED
Tilføjet 13.01.2025
3
PRO/EDR> Respiratory infections - Algeria: COVID-19 subvariant, susp, RFI
ProMED
Tilføjet 13.01.2025
4
PRO/ALL> New in IJID (01): January 2025
ProMED
Tilføjet 12.01.2025
5
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021
Morbidity and Mortality Weekly Report (MMWR)
Tilføjet 12.01.2025
6
PRO/EDR> Respiratory infections - Northern Hemisphere: WHO, trends
ProMED
Tilføjet 11.01.2025
7
New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021
Morbidity and Mortality Weekly Report (MMWR)
Tilføjet 11.01.2025
8
Nationwide population-based infection- and vaccine-induced SARS-CoV-2 antibody seroprevalence in Germany in autumn/winter 2021/2022
Eurosurveillance latest updates
Tilføjet 11.01.2025
9
Reducing Risk, One Mask at a Time: What the Science Says
Medscape Infectious Diseases
Tilføjet 9.01.2025
10
Drugmakers to Raise US Prices on Over 250 Medicines Starting Jan. 1
Medscape Infectious Diseases
Tilføjet 1.01.2025
11
US FDA Revokes Authorization for Four COVID Antibody Drugs
Medscape Infectious Diseases
Tilføjet 24.12.2024
12
Juleprognose: Covid-19-smitten er stabil, mens influenza og RS-virus ventes at stige
Statens Serum Institut
Tilføjet 20.12.2024
13
Surveillance of Human Adenovirus Types and the Impact of the COVID-19 Pandemic on Reporting - United States, 2017-2023
Morbidity and Mortality Weekly Report (MMWR)
Tilføjet 20.12.2024
14
Core protocol for ECDC studies of vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2 or with seasonal influenza Version 4.0
ECDC COVID-19 updates
Tilføjet 17.12.2024
15
Self-Replicating mRNA Vaccine for COVID Prevention
Medscape Infectious Diseases
Tilføjet 14.12.2024
16
Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024
Morbidity and Mortality Weekly Report (MMWR)
Tilføjet 13.12.2024
17
Direct and indirect effects of the COVID-19 pandemic on mortality: an individual-level population-scale analysis using linked electronic health records, Wales, United Kingdom, 2016 to 2022
Eurosurveillance latest updates
Tilføjet 13.12.2024
18
Nuvaxovid NVX-CoV2373 vaccine safety profile: real-world data evidence after 100,000 doses, Australia, 2022 to 2023
Eurosurveillance latest updates
Tilføjet 13.12.2024
19
Reporting Protocol for integrated respiratory virus surveillance
ECDC COVID-19 updates
Tilføjet 5.12.2024
20
BCG Vaccine May Protect Against Long COVID Symptoms
Medscape Infectious Diseases
Tilføjet 3.12.2024
21
COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in eight European countries in the VEBIS monitoring network - October 2023 to April 2024
ECDC COVID-19 updates
Tilføjet 3.12.2024
22
Opdateret covid-19-vaccine giver markant beskyttelse til ældre
Statens Serum Institut
Tilføjet 22.11.2024
23
Detection of Real-Time Changes in Direction of COVID-19 Transmission Using National- and State-Level Epidemic Trends Based on Rt Estimates - United States Overall and New Mexico, April-October 2024
Morbidity and Mortality Weekly Report (MMWR)
Tilføjet 22.11.2024
24
Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024
Morbidity and Mortality Weekly Report (MMWR)
Tilføjet 22.11.2024
25
Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2024
Morbidity and Mortality Weekly Report (MMWR)
Tilføjet 22.11.2024